Envestnet Asset Management Inc Blueprint Medicines Corp Transaction History

Envestnet Asset Management Inc

$302 Billion
Q3 2024

A detailed history of Envestnet Asset Management Inc transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Envestnet Asset Management Inc holds 28,392 shares of BPMC stock, worth $2.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

28,392

Previous 22,685 25.16%

Holding current value

$2.6 Million

Previous $2.44 Million 7.41%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	BUY	$84.1 - $120.5 $479,958 - $687,693	5,707 Added 25.16%	28,392 $2.63 Million
Q2 2024 Aug 08, 2024	SELL	$85.18 - $108.78 $21,039 - $26,868	-247 Reduced 1.08%	22,685 $2.44 Million
Q1 2024 May 13, 2024	BUY	$73.17 - $99.79 $44,121 - $60,173	603 Added 2.7%	22,932 $2.18 Million
Q4 2023 Feb 13, 2024	BUY	$43.96 - $92.84 $131,440 - $277,591	2,990 Added 15.46%	22,329 $2.06 Million
Q3 2023 Nov 13, 2023	BUY	$46.9 - $66.0 $163,962 - $230,736	3,496 Added 22.07%	19,339 $971,000
Q2 2023 Aug 04, 2023	BUY	$42.2 - $66.37 $92,544 - $145,549	2,193 Added 16.07%	15,843 $1 Million
Q1 2023 May 11, 2023	BUY	$37.97 - $50.0 $18,567 - $24,450	489 Added 3.72%	13,650 $614,000
Q4 2022 Feb 07, 2023	SELL	$41.06 - $66.48 $50,585 - $81,903	-1,232 Reduced 8.56%	13,161 $576,000
Q3 2022 Nov 10, 2022	BUY	$49.93 - $77.7 $26,013 - $40,481	521 Added 3.76%	14,393 $948,000
Q2 2022 Aug 03, 2022	BUY	$45.23 - $70.15 $57,894 - $89,792	1,280 Added 10.17%	13,872 $701,000
Q1 2022 May 04, 2022	SELL	$54.1 - $110.08 $75,361 - $153,341	-1,393 Reduced 9.96%	12,592 $804,000
Q4 2021 Feb 04, 2022	SELL	$94.25 - $115.99 $301,600 - $371,168	-3,200 Reduced 18.62%	13,985 $1.5 Million
Q3 2021 Oct 07, 2021	BUY	$80.98 - $109.47 $54,904 - $74,220	678 Added 4.11%	17,185 $1.77 Million
Q2 2021 Aug 04, 2021	BUY	$82.78 - $101.0 $167,381 - $204,222	2,022 Added 13.96%	16,507 $1.45 Million
Q1 2021 May 04, 2021	BUY	$90.71 - $108.28 $223,237 - $266,477	2,461 Added 20.47%	14,485 $1.41 Million
Q4 2020 Feb 02, 2021	BUY	$92.08 - $124.48 $119,611 - $161,699	1,299 Added 12.11%	12,024 $1.35 Million
Q3 2020 Oct 09, 2020	SELL	$66.45 - $92.7 $304,141 - $424,287	-4,577 Reduced 29.91%	10,725 $994,000
Q2 2020 Jul 08, 2020	BUY	$57.09 - $79.27 $873,591 - $1.21 Million	15,302 New	15,302 $1.19 Million

Others Institutions Holding BPMC

# of Institutions

351

Shares Held

60.3M

Call Options Held

2.25M

Put Options Held

1.18M

View Full List

About Blueprint Medicines Corp

Ticker BPMC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,719,600
Market Cap $5.47B
Description
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...

More about BPMC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.

Account

Envestnet Asset Management Inc Blueprint Medicines Corp Transaction History